Zhenbin Li

775 total citations
7 papers, 16 citations indexed

About

Zhenbin Li is a scholar working on Rheumatology, Complementary and alternative medicine and Hematology. According to data from OpenAlex, Zhenbin Li has authored 7 papers receiving a total of 16 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 3 papers in Complementary and alternative medicine and 2 papers in Hematology. Recurrent topics in Zhenbin Li's work include Rheumatoid Arthritis Research and Therapies (3 papers), Spondyloarthritis Studies and Treatments (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). Zhenbin Li is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (3 papers), Spondyloarthritis Studies and Treatments (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). Zhenbin Li collaborates with scholars based in China. Zhenbin Li's co-authors include Dong Xu, Qingjun Wu, Zhuoli Zhang, Yan Zhao, Zihan Wang, Ming Li, Yudong Liu, Jiangyun Peng, Hongbin Li and Liyun Zhang and has published in prestigious journals such as Scientific Reports, Clinical Immunology and Saudi Journal of Biological Sciences.

In The Last Decade

Zhenbin Li

6 papers receiving 15 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenbin Li China 3 9 6 5 3 2 7 16
William Honeycutt United States 3 7 0.8× 6 1.0× 5 1.7× 2 1.0× 4 17
Carla Sans‐Pola Spain 3 7 0.8× 10 1.7× 3 1.0× 5 18
A. S. Patron Finland 2 8 0.9× 2 0.3× 2 0.4× 4 10
James Perera United Kingdom 1 6 0.7× 8 1.3× 1 0.2× 6 2.0× 1 0.5× 2 18
Hongguo Zhu China 3 8 0.9× 9 1.5× 2 0.4× 1 0.3× 3 18
Rafik Mesbah France 3 5 0.6× 5 0.8× 3 1.5× 4 19
Tanya Baqai United Kingdom 3 11 1.2× 3 0.5× 1 0.3× 4 13
María Dolores Sánchez de la Nieta Spain 3 6 0.7× 3 0.5× 5 12
Camilla Zettel Norway 1 14 1.6× 11 1.8× 1 0.3× 1 0.5× 2 15
M. J. Brown 3 11 1.2× 6 1.0× 1 0.3× 4 2.0× 3 24

Countries citing papers authored by Zhenbin Li

Since Specialization
Citations

This map shows the geographic impact of Zhenbin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenbin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenbin Li more than expected).

Fields of papers citing papers by Zhenbin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenbin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenbin Li. The network helps show where Zhenbin Li may publish in the future.

Co-authorship network of co-authors of Zhenbin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenbin Li. A scholar is included among the top collaborators of Zhenbin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenbin Li. Zhenbin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Zhao, Longmei, Shasha Zhou, Rui Wu, et al.. (2024). Zhuifeng Tougu capsules in the treatment of knee osteoarthritis (cold dampness obstruction syndrome): a randomized, double blind, multicenter clinical study. Chinese Medicine. 19(1). 18–18. 1 indexed citations
3.
Zhang, Xuan, Huaxia Yang, Xiaoxia Zuo, et al.. (2023). Efficacy and safety of tripterygium wilfordii Hook F plus TNF inhibitor for active rheumatoid arthritis: A multicentre, randomized, double-blind, triple-dummy controlled trial. Clinical Immunology. 255. 109749–109749. 5 indexed citations
4.
Wu, Qingjun, Yan Zhao, Dong Xu, Zhuoli Zhang, & Zhenbin Li. (2020). Efficacy of methotrexate and etanercept biosimilar rhTNFR:Fc in Chinese patients with active rheumatoid arthritis: A controlled, randomized and multicenter study. Scientific Reports. 10(1). 14270–14270. 4 indexed citations
5.
Meng, Chen, Zhenbin Li, Zheng Zhang, et al.. (2018). Intervention of integrative medicine treatment has impact on serum levels of ET-1, TNF-α, MLT in RA-CVD. Saudi Journal of Biological Sciences. 25(5). 959–964. 1 indexed citations
6.
Feng, Xinghua, Quan Jiang, Huadong Zhang, et al.. (2013). [Clinical effect analysis of ankylosing spondylitis treated by Chinese medical syndrome differentiation].. PubMed. 33(10). 1309–14. 2 indexed citations
7.
Wu, Qingjun, Zhenbin Li, Xu D, et al.. (2010). [An open-label, multicentric clinical trial to evaluate the efficacy and impact on bone metabolism of recombinant human tumor necrosis factor-α receptor II IgG Fc fusion protein with methotrexate in active rheumatoid arthritis: 24-week clinical and radiographic results from ReABLE study].. PubMed. 90(35). 2481–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026